View Older Stories
-
RBC Capital on Boston Scientific (BSX): 'We See the I-Day as a Clearing Event'
-
RBC Capital on Boston Scientific (BSX): 'Bullish on Next Leg of Growth'
-
Boston Scientific (BSX) PT Raised at RBC Capital on 'Strong Business Momentum'
-
These 30 global stocks offer tactical and structural upside, says RBC
-
Boston Scientific (BSX) PT Raised at RBC Capital Following 'Encouraging Guidance Raise'
-
RBC Capital on Boston Scientific (BSX): 'We See Room for a Beat and Raise'
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
RBC Capital on Boston Scientific (BSX): 'Strong Near-Term Trends With Visibility On Growth Durability'
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
Boston Scientific (BSX) PT Raised to $116 at RBC; 'Solid PFA & Broad Portfolio Momentum Offer Room for 2025 Upside'
-
RBC Capital on Boston Scientific (BSX): 'Consistent Top Performer That Isn't Slowing Down'
-
RBC's Best Picks For 2025 in Medical Supplies & Devices: 'Oasis of Opportunity Awaits as MedTech Momentum Continues'
-
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
-
Boston Scientific (BSX) PT Raised to $82 at RBC Capital
-
RBC on Boston Scientific (BSX) Long-Range Plan Released Earlier at Investor Day, 'we are encouraged
-
Boston Scientific Announces Pricing Terms of Its Cash Tender Offer
-
Boston Scientific Announces Early Results of Its Cash Tender Offer for Its Outstanding Debt Securities and Increases Aggregate Maximum Principal Amount of Its Cash Tender Offer
-
RBC Capital Starts Boston Scientific (BSX) at Outperform
-
Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock
-
Boston Scientific (BSX) Prices 25.5M Share Common Offering at $34.25/Sh; Announces Pricing of 8.75M Mandatory Convertible Preferred Offering at $100/Sh
-
Boston Scientific Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
-
Boston Scientific (BSX) PT Raised to $46 at RBC Capital Into Investor Day
-
Boston Scientific (BSX) PT Raised to $42 at RBC Capital; Momentum to Continue
-
Boston Scientific (BSX) PT Raised to $36 at RBC Capital Ahead of 2Q Release
-
A Stryker (SYK)/Boston Scientific (BSX) Combo Would Be 'Unfavorable' - RBC
-
UPDATE: RBC Capital Upgrades Boston Scientific (BSX) to Top Pick
-
Boston Scientific to Participate in 2017 RBC Capital Markets Global Healthcare Conference
-
Notable Analyst Rating Changes 6/9: (SCTY) (P) (LNKD) Upgraded; (SWKS) (NRG) (CHK) Downgraded
-
Notable Analyst Rating Changes 3/17: (SPN) (PLCE) (HLX) Upgraded; (CMG) (RH) (HP) Downgraded
-
Notable Analyst Rating Changes 2/25: (MSCC) (XRAY) (MLNX) Upgraded; (LC) (CNL) (EXAS) Downgraded
-
Notable Analyst Rating Changes 3/20: (OC) (HON) (AUY) Upgraded; (CCG) (EXTR) (UCTT) Downgraded
-
Notable Analyst Rating Changes 01/21: (BSX) (STX) (ALTR) Upgraded; (DDD) (AAPL) (SCTY) Downgraded
-
Notable Analyst Rating Changes 04/03: (EAT) (NKA) (DLTR) Upgraded; (BSX) (LM) (CAT) Downgraded
-
Notable Analyst Rating Changes 08/18: (SINA) (UDR) (BIIB) Upgraded; (NTAP) (GT) (IR) Downgraded
-
Notable Analyst Rating Changes 03/01: (LVS) (BSX) Upgraded; (NHP) (SWN) Downgraded
-
RBC Capital Upgrades Boston Scientific (BSX) to Outperform
-
Daily State of the Markets: Seeing What They Want to See?
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
Notable Analyst Rating Changes 03/16: SBUX, CLX, MPEL, UFS Upgraded; BSX, SQNM, WU, EAT Downgraded
-
RBC Capital Downgrades Boston Scientific (BSX) to Sector Outperform
-
Notable Analyst Rating Changes 03/15: WMT, RAX, LGF, SIRO Upgraded; BSX, ACI, HCP, ICE, SLE, ARMH, AKAM Downgraded
-
Notable Analyst Rating Changes for 02/12: MAR, RIMM, CBS, DHI Upgraded; CML, CSTR, NILE, BSX Downgraded
-
Notable Analyst Rating Changes for 10/20: BAC, AMZN, F, BBT, DTE Upgrade; BSX, LEAP/PCS, BA, WFT, GME Downgrade
-
RBC Raises Estimates on Abbott (ABT), Lowers Estimates on Boston Scientific (BSX)
-
RBC Capital Initiates Coverage on Several Medical Instruments & Supplies/Drug Stocks - Abbott Labs Named Top Pick
-
David Moenning's Daily State of the Markets: 1/29
-
Unusual 11 Mid-Day Movers 4/16: POZN, SORC, EXM, GRO Higher; TLB, HCSG, GLG, CDL Lower

